PubMed Health⌕ Search

Biomedical subjects

T K Banerjee

Publications and source records attributed to T K Banerjee.

At least 19 recordsLinked to original sources
PubMed2006

Aicardi syndrome: a report of five Indian cases.

Five Indian cases of Aicardi syndrome, aged 1-13 years and all with the classic triad of infantile spasm, corpus callosal agenesis and chorioretinal lacunae, were presented. The purpose of this report was to demonstrate the clinical, electroencephalographic (EEG) and radiological spectrum and the treatment outcome of this disorder among the Indians. None of the patient had any family history of similar illness. All had profound psychomotor impairment with no meaningful speech development. There were microphthalmia in 2, optic disc coloboma in 1, interhemispheric cyst in 1, periventricular heterotopia in 2 and thoracolumbar kyphoscoliosis in 2 cases. They all had early onset epilepsy and there were multiple types of seizures. Two cases (40%) had the characteristic dissociated burst-suppression pattern in EEG. Two cases whose antiepileptic medications included vigabatrin had complete control of seizure.

Adolescent↗
PubMed2006

A random sample survey for prevalence of major neurological disorders in Kolkata.

BACKGROUND & OBJECTIVES: Large scale epidemiological studies on neurological disorders are very few in India. We therefore planned to conduct a cross-sectional population-based epidemiological study on a stratified randomly selected sample from the city of Kolkata to study the prevalence of major neurological disorders such as epilepsy, stroke, dementia and Parkinsonism. METHODS: The method of case ascertainment was two- stage house-to-house survey; the first stage was undertaken by a field team consisting of four field workers and a neuropsychologist. Screening questionnaire based on National Institute of Mental Health and Neuro Sciences (NIMHANS) protocol was used. In the second stage a neurologist examined all the screened positive cases. RESULTS: A total of 52,377 subjects participated in the study. The crude prevalence rates (per 100,000 population) of major neurological disorders with 95 per cent confidence intervals (95% CI) and age adjusted rates (AAR) based on US 2000 population were 557.5 (95% CI 496.17-624.40 and AAR - 516.77) in epilepsy, 486.85 (95% CI 377.0 to 551.11 and AAR-765.68) in stroke, 87.82 (95% CI 64.02-117.50 and AAR-168.4) in dementia and 45.82 (95% CI 29.64-67.63 and AAR-71.64) in Parkinsonism. The weighted prevalence rates (per 100,000) of the whole population based on re-screening of 10 per cent of negative samples were 763.89 (95% CI 690.55- 842.57) in epilepsy, 624.32 (95% CI 555.64-699.24) in stroke and 139.37 (95% CI 108.71-176.06) in dementia. INTERPRETATION & CONCLUSION: A high rate of stroke and overall lower prevalence of Parkinsonism and dementia was recorded as compared to western studies. High prevalence rate of stroke emphasizes the need to study incidence, morbidity and mortality profile of stroke including its socio-economic impact and also case-control analysis to determine the underlying risk factors.

Adolescent↗
PubMed2001

Stroke in the urban population of Calcutta--an epidemiological study.

A population-based cluster survey on stroke disorders was conducted for the first time in the city of Calcutta, India. The population surveyed totaled 50,291. The crude prevalence rate of stroke was 147/100,000 (age-adjusted prevalence 334/100,000). The annual incidence rate of stroke for the year 1998-1999 was 36/100,000 (age-adjusted annual incidence rate 105/100,000). Women outnumbered men regarding stroke prevalence in all age groups except in the 50- to 69-year age group. There were relatively more cases of cerebral haemorrhage in our study, compared to those in the western countries. Case-control analysis found hypertension to be the most significant risk factor for stroke.

Adolescent↗
PubMed2000

Replication linkage study for prostate cancer susceptibility genes.

BACKGROUND: Since the publication of the first genome screen for prostate cancer (CaP) 5 years ago, over a dozen linkage studies have appeared. Most attention has been directed to chromosome 1, where two separate regions have been identified as harboring a prostate cancer susceptibility locus: HPC1 in the 1q24-25 interval and PCaP in the 1q42.2-43 interval. Linkage analysis of chromosome 16 has also provided evidence of harboring two loci predisposing to CaP. METHODS: We report on a replication linkage study of chromosomes 1 and 16 in 45 new and 4 expanded multiplex CaP families. Multipoint Z-scores were obtained for 30 highly polymorphic short-sequence tandem repeat markers spanning chromosome 1, and 22 markers spanning chromosome 16. RESULTS: The replication sample gave no evidence for a CaP susceptibility locus in the 1q24-25 interval and equivocal evidence for such a locus at 1q42.2-43. With respect to chromosome 16, positive Z-scores were obtained over a contiguous interval covering the entire p arm and the proximal half of the q arm. CONCLUSIONS: The linkage analysis of our replication sample does not support the existence of HPC1, and the evidence for the existence of PCaP remains equivocal. Evidence of a susceptibility locus on 16p remains strong, but the evidence for a susceptibility locus on 16q is weakened.

Chromosomes, Human, Pair 1↗
PubMed2000

A genome screen of multiplex sibships with prostate cancer.

Analysis of a genome screen of 504 brothers with prostate cancer (CaP) who were from 230 multiplex sibships identified five regions with nominally positive linkage signals, on chromosomes 2q, 12p, 15q, 16p, and 16q. The strongest signal in these data is found on chromosome 16q, between markers D16S515 and D16S3040, a region suspected to contain a tumor-suppressor gene. On the basis of findings from previous genome screens of families with CaP, three preplanned subanalyses were carried out, in the hope of increasing the subgroup homogeneity. Subgroups were formed by dividing the sibships into a group with a positive family history (FH+) that met criteria for "hereditary" CaP (n=111) versus those which did not meet the criteria (n=119) and by dividing the families into those with a mean onset age below the median (n=115) versus those with a mean onset age above the median (n=115). A separate subanalysis was carried out for families with a history of breast cancer (CaB+ [n=53]). Analyses of these subgroups revealed a number of potentially important differences in regions that were nonsignificant when all the families were analyzed together. In particular, the subgroup without a positive family history (FH-) had a signal in a region that is proximal to the putative site of the HPC1 locus on chromosome 1, whereas the late-age-at-onset group had a signal on 4q. The CaB+ subgroup revealed a strong linkage signal at 1p35.1.

Age of Onset↗
PubMed1999

Diffuse central neuronal involvement in Fabry disease: a proton MRS imaging study.

BACKGROUND: The in vivo determination of parenchymal involvement is important to evaluate disease burden. Proton MRS imaging (1H-MRSI) permits simultaneous measurement of N-acetylaspartate (NA), a putative neuron-specific molecule, choline-containing compounds, creatine-phosphocreatine, and lactate from four 15-mm slices divided into 0.84-mL single-volume elements. OBJECTIVE: To assess the cortical and subcortical neuropathology in Fabry disease (FD). METHODS: Regions of interest (ROIs) were selected from several cortical and subcortical locations in nine FD patients. Mean ROI metabolite ratios were compared with control values. RESULTS: FD patients showed a widespread pattern of cortical and subcortical NA reduction. Seven patients showed discrete MRI abnormalities consisting of white matter hyperintensities or basal ganglia infarcts. CONCLUSION: We found diffuse neuronal involvement in FD extending beyond the areas of MRI-visible cerebrovascular abnormalities. 1H-MRSI may become useful in therapeutic trials.

Adult↗
PubMed1998

Quantitative analysis of cerebral vasculopathy in patients with Fabry disease.

OBJECTIVE: This study's purpose was to obtain a quantitative natural history of the cerebrovascular involvement in Fabry disease. BACKGROUND: Fabry disease is an X-linked recessive disorder due to alpha-galactosidase A deficiency. Progressive accumulation of ceramidetrihexoside within the intima and media of cerebral blood vessels causes ischemic lesions in the majority of affected patients. Determination of the natural history of the cerebral vasculopathy in Fabry disease is important to assess the effects of therapeutic intervention in this disorder. METHODS: A longitudinal MRI study of 50 patients who had a total of 129 MRI scans was performed. The burden of cerebrovascular disease was determined using direct linear measurement. RESULTS: On T2-weighted MRI scans, 32% of the patients had no lesions (mean age, 33 years), 16% had gray matter lesions only (mean age, 36 years), 26% had lesions in white matter only (mean age, 43 years), and 26% had lesions in white and gray matter (mean age, 47 years). Disease burden increased with age, but no patient younger than 26 had lesions on MRI. All patients older than 54 had cerebrovascular involvement. The distribution of MRI-detectable lesions was typical of a small-vessel disease. Only 37.5% of patients with cerebral lesions had neurologic symptoms. CONCLUSION: These findings provide a predictable outcome measure to assess the effect of molecular interventions on the cerebrovascular circulation in Fabry disease.

Adolescent↗
PubMed1998

Initial control of chemotherapy-induced nausea and vomiting in patient quality of life.

The side effects commonly experienced by patients receiving chemotherapy for the treatment of cancer can challenge many aspects of daily life. Nausea and vomiting, the most common side effects reported by patients, affect the ability to continue with usual life activities and, thus have a pronounced impact on quality of life. This paper reviews studies of the impact of nausea and emesis on quality of life, and highlights the importance of prevention of these side effects by presenting new data on how persistent uncontrolled nausea and vomiting can be. The Morrow Assessment of Nausea and Emesis (MANE) was used to collect information on symptoms experienced by consecutive patients starting chemotherapy between September 1987 and December 1995 at any of 18 geographically diverse member sites of the University of Rochester Cancer Center Community Clinical Oncology Program. Data from 1,413 patients were collected after each of four successive chemotherapy treatments. Reported incidences of posttreatment nausea and posttreatment vomiting after the first treatment were 59.4% and 28.6%, respectively. Occurrence of nausea/vomiting at the first treatment was a strong predictor of nausea/vomiting at later treatments. Of the 839 patients reporting initial nausea, 763 (90.9%) reported nausea at at least one subsequent treatment, and approximately 59% reported nausea after all three subsequent treatments. Fewer than half (45.6%) of the patients who had no nausea at the first treatment developed it later. The majority (72.0%) of patients reporting vomiting at the first treatment also reported subsequent vomiting, 30.7% of whom experienced emesis at all remaining treatments. Conversely, 76.2% of patients who were emesis-free at the first treatment remained so for all later treatments. These findings show a continuing need for further progress in controlling nausea and vomiting, and demonstrate the importance of aggressive nausea/vomiting control at the first treatment. In addition, more emphasis on controlling chemotherapy-induced nausea after its initial occurrence is necessary.

Antineoplastic Agents↗
PubMed1997

Histopathological analysis of sublethal toxicity of zinc chloride to the respiratory organs of the airbreathing catfish Heteropneustes fossilis (Bloch).

Sublethal toxicity of zinc chloride (ZnCl2; 7.5 ppm: 10% of 96 h LC50 value) on the aerial (accessory respiratory organs or air sacs) and branchial (gills) respiratory organs of Heteropneustes fossilis has been analysed histopathologically. Zinc chloride exposure cause certain common but severe damage to both tissues. The prominent changes in the accessory respiratory organs include periodic deformation of lamellar elements, haemorrhages due to necrosis and sloughing off of the respiratory epithelium, and hyperplasia accompanied by fusion of secondary lamellae. Subsequently, regeneration of the lamellar system from the focal inflammatory tissues takes place. Deposition of glycogen in the muscular layer indicates disturbed aerial respiration. The alterations in the gills include periodic lifting off of the respiratory epithelium, extensive intercellular vacuolization and occasional fusion of secondary lamellae, resulting in increased thickness of primary and secondary lamellae. Fusion of secondary lamellae reduces the surface area for gaseous exchange. The increased thickness of the respiratory epithelium due to uncontrolled hyperplasia of the epithelial cells, also increases the diffusion distance between the ambient and vascular components. Vasodilation in the secondary lamellae of the gills and periodic fluctuations in the mucous cell density are also observed at various stages of ZnCl2 exposure.

Air Sacs↗
PubMed1995

Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources.

OBJECTIVE: To compare the efficacy of mannose-terminated glucocerbrosidase prepared from natural (alglucerase; Ceredase, Genzyme Corp., Cambridge, Massachusetts) and recombinant (imiglucerase; Cerezyme, Genzyme Corp.) sources in treating type 1 Gaucher disease. DESIGN: Double-blind, randomized, parallel trial. SETTING: University medical center and clinical research hospital. PATIENTS: 15 patients (4 children and 11 adults) randomly assigned to receive Ceredase and 15 patients (3 children and 12 adults) assigned to receive Cerezyme. INTERVENTION: Ceredase and Cerezyme were infused every 2 weeks for 9 months at a dose of 60 U/kg body weight. OUTCOME MEASURES: Hemoglobin levels, platelet counts, and serum acid phosphatase and angiotensin-converting enzyme activities were monitored every 2 weeks during the trial. Hepatic and splenic volumes were assessed at the time of randomization and after 6 and 9 months of enzyme infusion. Formation of IgG antibodies to Ceredase or Cerezyme was monitored every 3 months by radioimmunoprecipitation assay. RESULTS: No significant differences were found in the rate or extent of improvement in hemoglobin levels, platelet counts, serum acid phosphatase or angiotensin-converting enzyme activities, or hepatic or splenic volumes between either treatment group. The incidence of IgG antibody formation was greater in the Ceredase group (40%) than in the Cerezyme group (20%). No major immunologic adverse events occurred in either group. CONCLUSIONS: Our study shows the therapeutic similarity of Ceredase and Cerezyme. Cerezyme has the advantage of being theoretically unlimited in supply and free of potential pathogenic contaminants.

Adolescent↗
PubMed1995

Melanophore indexing: a new bio-assay technique for the analysis of acute heavy metal (HgCl2) toxicity.

Toxicity of 0.3 ppm (96 h LC50 value) and 0.03 ppm of mercuric chloride on the melanophores of the skin at different time intervals has been studied. Mercury treatment causes immediate increase in the number and size of the pigment cells. Subsequently these pigment cells form a dense matting of melanophore network with their cell processes interlacing with those of their neighbours. These cells later show degeneration and lysis releasing large quantity of pigment granules into the intercellular spaces in the dermis. Later the pigment cells regenerate several times each followed by degeneration in a cyclic manner. Prolonged treatment with sublethal concentration of mercuric chloride does not show significant alteration in the melanophore density and size. Statistical analysis and wide spread destruction of melanophores observed during 4-6 days of exposure might help in testing water samples contaminated with lethal concentration of heavy metal salts.

Animals↗
PubMed1995

Myasthenia gravis.

Explore the source record for details and available documents.

Autoantibodies↗
PubMed1993

Magnetic stimulation in the determination of lumbosacral motor radiculopathy.

Magnetic stimulation was utilised to diagnose lumbosacral motor radiculopathy non-invasively. Magnetic coil stimulation estimated peripheral motor nerve conduction time (MNCT) which, used in combination with F response, allowed calculation of "motor root conduction time (MRCT)," response being recorded from abductor hallucis. Twenty-five normal controls and 26 patients with lumbar spondylosis were studied. The mean interside difference (left minus right) of MRCT in the control was +0.06 msec (range: -0.88 to +0.74 msec). On clinical and radiological grounds, patients with spondylosis were grouped into those with: (I) no lumbosacral root compression, (II) root compression without motor sign, and (III) root compression with motor deficit. All patients in group III and 36% of cases of group II had MRCT significantly prolonged on the affected side.

Adult↗
PubMed1993

Histopathological changes in the epidermis of the air breathing catfish Heteropneustes fossilis exposed to sublethal concentration of mercuric chloride.

Histopathological alterations induced by the sublethal concentration of (0.03 ppm) mercuric chloride solution on the epidermis of the fresh-water catfish Heteropneustes fossilis have been studied. It induces slow but significant histopathological changes in the various cellular components of the epidermis. It induces vacuolization, necrosis and pycnosis of the nuclei of the epithelial cells which subsequently shed. Loosening of epithelial cells of the outermost and middle layers following degeneration of the intercellular material and widened intercellular spaces is another important alteration. Prolonged mercury treatment also causes a gradual decrease in staining intensity for sulphated glycosaminoglycans in the outer border of the most superficial layer epithelial cells. The glandular elements (club cells and mucocytes) also get affected, showing cyclic degeneration followed by regeneration.

Animals↗